Search research articles
Contact Us
Filters
Showing results (1-10 of 141) with videos related to
Page
of 15
Sort By:
Hormone Research in Paediatrics
|
January 17, 2025
The Central Control of Energy Metabolism: Hypothalamic Obesity Is Not One Disease
Hanneke M van Santen
European Journal of Endocrinology
|
November 2, 2020
Safety of GH after treatment for childhood cancer
Hanneke M van Santen
The Lancet Regional Health. Europe
|
December 15, 2025
Pediatric thyroid cancer in Europe: time to act and rethink care
Sarah C Clement, Hanneke M van Santen
Endocrine Reviews
|
August 1, 2025
Management of Acquired Hypothalamic Dysfunction and the Hypothalamic Syndrome; it is more than obesity
Hanneke M van Santen, Hermann L Müller
Frontiers of Hormone Research
|
September 28, 2021
Preface
Enrico Brignardello, Francesco Felicetti, Hanneke M van Santen
Oncotargets and Therapy
|
January 19, 2017
Pediatric papillary thyroid cancer: current management challenges
Frederik A Verburg, Hanneke M Van Santen, Markus Luster
Frontiers in Endocrinology
|
January 19, 2024
Could setmelanotide be the game-changer for acquired hypothalamic obesity?
Hanneke M van Santen, Christian Denzer, Hermann Lothar Müller
Frontiers of Hormone Research
|
March 10, 2021
Thyroid Dysfunction and Thyroid Cancer in Childhood Cancer Survivors: Prevalence, Surveillance and Management
Chantal A Lebbink, Steven G Waguespack, Hanneke M van Santen
Best Practice & Research. Clinical Endocrinology & Metabolism
|
April 29, 2025
Growth hormone replacement therapy in childhood-onset craniopharyngioma
Laura van Iersel, Jiska van Schaik, Hanneke M van Santen
Nederlands Tijdschrift Voor Geneeskunde
|
July 10, 2014
[Primary amenorrhoea and macrocephaly]
Mark R Garrelfs, W Peter Vandertop, Hanneke M van Santen
Page
of 15
Search research articles
Search
Showing results (1-10 of 141) with videos related to
Sort By:
Page
of 15
Hormone Research in Paediatrics
|
January 17, 2025
The Central Control of Energy Metabolism: Hypothalamic Obesity Is Not One Disease
Hanneke M van Santen
European Journal of Endocrinology
|
November 2, 2020
Safety of GH after treatment for childhood cancer
Hanneke M van Santen
The Lancet Regional Health. Europe
|
December 15, 2025
Pediatric thyroid cancer in Europe: time to act and rethink care
Sarah C Clement, Hanneke M van Santen
Endocrine Reviews
|
August 1, 2025
Management of Acquired Hypothalamic Dysfunction and the Hypothalamic Syndrome; it is more than obesity
Hanneke M van Santen, Hermann L Müller
Frontiers of Hormone Research
|
September 28, 2021
Preface
Enrico Brignardello, Francesco Felicetti, Hanneke M van Santen
Oncotargets and Therapy
|
January 19, 2017
Pediatric papillary thyroid cancer: current management challenges
Frederik A Verburg, Hanneke M Van Santen, Markus Luster
Frontiers in Endocrinology
|
January 19, 2024
Could setmelanotide be the game-changer for acquired hypothalamic obesity?
Hanneke M van Santen, Christian Denzer, Hermann Lothar Müller
Frontiers of Hormone Research
|
March 10, 2021
Thyroid Dysfunction and Thyroid Cancer in Childhood Cancer Survivors: Prevalence, Surveillance and Management
Chantal A Lebbink, Steven G Waguespack, Hanneke M van Santen
Best Practice & Research. Clinical Endocrinology & Metabolism
|
April 29, 2025
Growth hormone replacement therapy in childhood-onset craniopharyngioma
Laura van Iersel, Jiska van Schaik, Hanneke M van Santen
Nederlands Tijdschrift Voor Geneeskunde
|
July 10, 2014
[Primary amenorrhoea and macrocephaly]
Mark R Garrelfs, W Peter Vandertop, Hanneke M van Santen
Page
of 15